Per-Visit, Membership, or Bundled Meds: Pricing Telehealth Care

On this page 8 sections

1. The Three Telehealth Pricing Models in Practice
2. Per-Visit Fees: Simple but Lumpy Revenue
3. Memberships: Predictable Revenue With More Dispute Risk
4. Bundling Medication Into the Price: Margins and Pharmacy Pass-Through
5. How Each Telehealth Pricing Model Looks to a Processor's Underwriter
6. Refunds and Denied Prescriptions Under Each Model
7. Choosing a Model by Condition Type and Patient Lifetime Value
8. Next Steps

Key takeaways

• Per-visit pricing is the easiest to underwrite and refund, but revenue rises and falls with patient demand.
• Memberships smooth cash flow but add recurring-billing disputes, so disclosures and easy cancellation matter.
• Bundling medication raises tickets and margins, but it can make you look like an online pharmacy to underwriters.
• Charging the consult and the medication separately makes denied prescriptions far easier to handle under any model.

Choosing a telehealth pricing model is a product decision and a payments decision at the same time. How you charge patients shapes your cash flow and how often you face chargebacks. It also determines how messy refunds get when a clinician declines to prescribe and how a processor's underwriting team sizes up your risk. This guide compares the three structures most direct-to-consumer practices use: per-visit fees, memberships, and prices that bundle medication. It also shows how to match each one to the conditions you treat.

The Three Telehealth Pricing Models in Practice

Most cash-pay virtual care businesses use one of these structures or a hybrid:

• Per-visit: The patient pays once for a live video visit or an asynchronous review of an intake questionnaire. Any prescription goes to a pharmacy, and the patient pays the pharmacy separately.
• Membership: The patient pays a recurring monthly, quarterly, or annual fee for ongoing access, such as follow-ups, messaging, and refills. Medication may or may not be included.
• Bundled medication: One price covers the clinical consult and the medication, which a partner pharmacy dispenses and ships. This model is often billed monthly, so it overlaps with memberships.

Each model looks different on a processing statement and in a risk file. Understanding those differences before you launch saves you from repricing or switching processors later.

Per-Visit Fees: Simple but Lumpy Revenue

Per-visit pricing is the most familiar model for patients and the easiest to explain at checkout. The patient pays for one encounter and owes nothing more unless they come back.

Cash flow. Revenue arrives at the time of service. That's clean, but it's also uneven. Demand for acute care rises and falls with seasons, marketing spend, and news cycles. You may see heavy weeks during cold and flu season and quiet stretches afterward, while clinician and platform costs stay fixed.

Chargeback exposure. Tickets are relatively small and the service is delivered right away, so exposure per transaction is low. The most common disputes come from patients who expected a prescription and didn't get one, and from fraudulent cards used to buy consults.

Async Consult Fees and Live Visits

An async consult fee covers a clinician's review of a patient-submitted questionnaire, usually without a live call. Async consults tend to be priced lower than video visits, and many practices offer both.

The payment risk is a gap in perception. A patient who filled out a form and got a message back may not feel they received a "visit," especially if the answer was no. Reduce that friction with three steps:

1. State at checkout that the fee pays for a clinical evaluation, not a guaranteed prescription.
2. Send a written summary of the clinician's decision through the patient portal.
3. Use a billing descriptor patients will recognize, ideally your brand name, without naming the condition being treated.

Memberships: Predictable Revenue With More Dispute Risk

Memberships turn episodic care into recurring revenue, which makes staffing and forecasting much easier. They fit conditions that need regular check-ins or refills.

Telehealth Membership vs. Per-Visit Billing

The tradeoff in telehealth membership vs. per-visit pricing is predictability against dispute risk. Recurring charges create dispute types that one-time charges rarely do:

• Patients forget they signed up and don't recognize the charge.
• Patients believe they canceled and claim the renewal wasn't authorized.
• Patients stop using the service but keep getting billed.

Card network rules for recurring transactions, along with state automatic-renewal laws, generally require clear disclosure of terms, express consent, and a workable way to cancel. Requirements vary by network and state, so confirm the current rules with your processor and a qualified attorney. In practice, reliable habits include:

• Showing the recurring amount, billing frequency, and cancellation method next to the payment button
• Sending a confirmation after signup and a reminder before renewals, especially annual ones
• Offering online cancellation that doesn't require a phone call

For storing payment credentials correctly, see our guide on card-on-file billing for virtual visits.

Prepaid annual plans deserve extra thought. Collecting a year of fees up front helps cash flow, but it creates future-delivery exposure. If your practice shut down, the processor could be liable for refunds on months of undelivered care. Underwriters weigh that risk, and it can lead to reserves or holds.

Bundling Medication Into the Price: Margins and Pharmacy Pass-Through

Bundled pricing gives patients one number and one checkout, which many prefer. It can also improve your margins, because you set the retail price for the full package.

How Bundled Medication Pricing Changes Your Risk Profile

With bundled medication pricing, telehealth practices take on pharmacy economics:

• Pass-through costs. You collect from the patient and then pay the partner pharmacy. If the pharmacy bills you at dispensing and a reserve or hold delays your settlement, your cash gap widens.
• Higher tickets. Medication raises the transaction amount, which raises exposure on every dispute and fraud attempt. Stolen cards are a known problem for practices selling high-demand prescriptions. Our article on online pharmacy fraud with stolen cards covers the patterns.
• Shipping disputes. Physical products bring "item not received" claims, so tracking and delivery confirmation become part of your dispute evidence.
• Legal structure. How a practice and a pharmacy split revenue can raise state-law questions, including fee-splitting and corporate practice of medicine rules. Have a healthcare attorney review the arrangement.

Compounded medications draw additional scrutiny from processors. If that applies to you, read why processors drop compounded GLP-1 clinics before you apply.

How Each Telehealth Pricing Model Looks to a Processor's Underwriter

Underwriters don't approve or decline a pricing model by name. They evaluate what the model implies about risk. Telehealth is generally treated as high risk to begin with, a topic covered in our guide to why telehealth merchant accounts are high risk. Your pricing structure then adds or removes specific concerns.

Whatever model you choose, expect underwriters to review:

• Your website's pricing, terms, refund policy, and recurring disclosures
• Proof that a licensed clinician evaluates every patient before prescribing
• Whether controlled substances are involved, which brings its own federal and state requirements
• Who dispenses and ships medication, and whether that pharmacy is properly licensed
• Processing history, including past chargeback ratios

A bundled model can also affect how your account is classified, because charging for medication can make you resemble an online pharmacy. Our breakdown of online pharmacy credit card fees and MCC classification explains why classification matters. Never describe your business inaccurately to get a different classification. Miscoding violates card network rules and can end in termination.

Refunds and Denied Prescriptions Under Each Model

Denied prescriptions are the moment where telehealth pricing either holds up or falls apart. The clinician did the work, but the patient didn't get what they came for.

Per-visit. The cleanest approach is to charge for the evaluation regardless of outcome and disclose that clearly before payment. Some practices offer a partial refund or credit on denial as a goodwill gesture. Whatever you choose, make the policy consistent and visible.

Membership. If the first consult ends in a denial, decide in advance whether you refund the first period, pause the membership, or cancel automatically. Continuing to bill a patient who was told the service isn't right for them invites disputes.

Bundled. This is where structure matters most. Medication generally can't be restocked once it's dispensed, so confirm the specifics with your pharmacy partner. A two-step charge keeps refunds manageable:

1. Charge the consult fee at intake.
2. Charge the medication portion only after the clinician approves the prescription and the order goes to the pharmacy.

If you take a single upfront payment instead, a denial means refunding the medication portion every time, and you may pay processing costs on money you hand back.

Illustrative example: A practice sells a bundled monthly plan. If it charges the full bundle at signup and the clinician denies a portion of requests, each denial becomes a partial refund, and some patients file disputes anyway. Charging the consult first and the medication after approval removes most of those refunds.

For deeper playbooks, see handling telehealth refunds when a prescription is denied and winning telehealth chargebacks without exposing PHI.

Choosing a Model by Condition Type and Patient Lifetime Value

The right direct-to-consumer telehealth pricing usually follows the care pattern, not a revenue target.

Think about patient lifetime value honestly. A membership only pays off if patients actually stay. An aggressive renewal setup that keeps billing disengaged patients usually backfires through disputes. If dosing or medication changes are common, read about billing GLP-1 subscriptions through dose changes before you lock in a bundled price.

Watch your dispute ratios closely after any pricing change. Recurring models in particular can push a merchant toward card network monitoring thresholds. Our guide on what triggers Visa dispute monitoring explains the warning signs.

Next Steps

Before you finalize pricing:

• Map each charge to a specific service or product the patient can identify.
• Separate consult fees from medication charges wherever possible.
• Write recurring disclosures and cancellation steps before launch, not after the first disputes.
• Have a healthcare attorney review pharmacy arrangements and state requirements. This article is general information, not legal or tax advice.
• Share your intended pricing model with your processor during underwriting so nothing surprises the risk team later.

MannyPay provides payment processing for telehealth and online pharmacy businesses. That includes high-risk merchant accounts, online payment gateways such as Authorize.net and NMI, and 3-D Secure authentication for card-not-present transactions. Approval depends on underwriting. To talk through how your pricing model affects your application, request a free processing quote. A MannyPay specialist responds within one business day.

ME

About the author

MannyPay Editorial Team

Beyond the Swipe's editorial desk researches the publication's guides and news and cites its sources in every article. Articles reviewed by a named MannyPay editor carry that editor's byline.

This article is for general educational purposes and is not legal, tax or financial advice. Card network rules and state laws change; confirm current requirements for your business.